Drug Name: Talvey
Indications: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies.
Active Ingredient: Talquetamab-tgvs
Company: Janssen Pharmaceutical Companies
Approval Date: 8/9/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761342s000lbl.pdf